TechNVision Ventures Limited submitted a corporate announcement to the Bombay Stock Exchange regarding the appointment of Dr. Ujwala as Director of Technical Product Management at Solix Technologies, its affiliate company.
The announcement was made via a letter dated June 2, 2026, addressed to the Corporate Relationship Department of BSE Limited, signed by Geetanjali Toopran, Whole Time Director & CFO of TechNVision Ventures Limited.
Appointment Details
Dr. Ujwala was appointed to lead subject matter expertise initiatives and drive business development across Life Sciences, regulated industries, and AI-powered digital transformation. Based in Mumbai, she will support strategic growth across India and North America.
Professional Background
Dr. Ujwala brings more than 22 years of experience spanning Global Pharmaceutical R&D, Clinical Research Operations, Pharmacovigilance, Regulatory Writing, and Digital Transformation across Pharmaceutical, Medical Device, and Biosimilar sectors.
She previously spent more than a decade building and scaling Nucleon Research, a Mumbai-based Contract Research Organization (CRO), where she expanded global business development and forged strategic client partnerships. Her work included delivering end-to-end operations across Pharmacovigilance, Medical Information, Clinical Research, and Regulatory Services.
Technical Expertise
During her tenure at Nucleon Research, she established Good Pharmacovigilance Practice (GVP)-compliant safety systems, SOP-driven operational frameworks, and GDPR-compliant cloud-based Medical Information Call Center (MICC) operations supporting pharmaceutical clients across India and North America.
She built inspection-ready quality systems that successfully supported USFDA inspections and multiple global vendor qualification audits. Her domain expertise spans global clinical trial operations across Respiratory, Dermatology, Vaccines, Ophthalmology, and Oncology therapeutic areas.
Role at Solix Technologies
At Solix Technologies, Dr. Ujwala will focus on AI-driven digital transformation, regulatory technology platforms, enterprise data modernization, and next-generation digital solutions purpose-built for Life Sciences and regulated industries.
Management Commentary
Murali Krishnam of Solix Technologies stated: "The Life Sciences industry is undergoing a fundamental transformation driven by AI, data modernization, and increasingly complex regulatory requirements. Leaders who combine deep domain expertise with operational excellence and digital innovation are critical to helping organizations navigate this shift."